In addition to the COX-2-dependent pathway, celecoxib was able to directly inhibit and induce apoptosis of low-grade gliomas via the Akt/surviving and Akt/ID3 pathways, respectively [56]. This evidence concerns the gene AKT1 and central nervous system cancer.